| scholarly article | Q13442814 |
| P2093 | author name string | Min Hu | |
| Jijie Chai | |||
| Peiyuan Liu | |||
| Xinmiao Xing | |||
| Yin Zhang | |||
| Zhifu Han | |||
| P2860 | cites work | Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Embryonic ectoderm development | Q21981822 |
| P304 | page(s) | 1306-15 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Structure | Q15709970 |
| P1476 | title | Structural basis of EZH2 recognition by EED | |
| P478 | volume | 15 |
| Q28259120 | A novel mutation in EED associated with overgrowth |
| Q34302726 | A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells |
| Q38718859 | An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED. |
| Q27665361 | Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2) |
| Q46288028 | Computational characterization of substrate and product specificities, and functionality of S-adenosylmethionine binding pocket in histone lysine methyltransferases from Arabidopsis, rice and maize |
| Q34996482 | Computational prediction of associations between long non-coding RNAs and proteins |
| Q46252089 | Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2. |
| Q36299135 | DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L. |
| Q48675669 | Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors |
| Q36245610 | Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED. |
| Q43125467 | Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2. |
| Q48727279 | EED-associated overgrowth in a second male patient |
| Q34393753 | EZH2: biology, disease, and structure-based drug discovery |
| Q33610902 | EZH2: not EZHY (easy) to deal. |
| Q34691625 | EZH2: novel therapeutic target for human cancer |
| Q91216637 | Engaging chromatin: PRC2 structure meets function |
| Q39261435 | Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma |
| Q36810306 | Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms |
| Q47726221 | First critical repressive H3K27me3 marks in embryonic stem cells identified using designed protein inhibitor. |
| Q21198854 | Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression |
| Q38906678 | H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer |
| Q58830255 | Histone Recognition by WD40 Proteins |
| Q34255738 | Inner workings and regulatory inputs that control Polycomb repressive complex 2 |
| Q41878428 | Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED. |
| Q29614511 | Mechanisms of polycomb gene silencing: knowns and unknowns |
| Q38180674 | Mind the methyl: methyllysine binding proteins in epigenetic regulation |
| Q30570945 | Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives |
| Q21128799 | Molecular architecture of human polycomb repressive complex 2 |
| Q33533377 | Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells |
| Q28115469 | PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED/WAIT1 |
| Q92254249 | PRC2 is high maintenance |
| Q34185471 | Perspectives on the discovery of small-molecule modulators for epigenetic processes |
| Q36918656 | Polycomb and the emerging epigenetics of pancreatic cancer |
| Q27319398 | Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance |
| Q91880620 | Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis |
| Q35894532 | Pseudomonas syringae effector protein AvrB perturbs Arabidopsis hormone signaling by activating MAP kinase 4. |
| Q93207151 | Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding |
| Q27657483 | Role of the polycomb protein EED in the propagation of repressive histone marks |
| Q37941688 | Structural Chemistry of Human SET Domain Protein Methyltransferases |
| Q27702306 | Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2 |
| Q39245946 | Structure of the PRC2 complex and application to drug discovery. |
| Q47948466 | Structure, mechanism, and regulation of polycomb repressive complex 2. |
| Q41942526 | Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer |
| Q27664983 | The Effect of Asp-His-Ser/Thr-Trp Tetrad on the Thermostability of WD40-Repeat Proteins |
| Q38344853 | The Multifunctions of WD40 Proteins in Genome Integrity and Cell Cycle Progression |
| Q33815083 | The central role of EED in the orchestration of polycomb group complexes. |
| Q61810737 | The ezh2(sa1199) mutant zebrafish display no distinct phenotype |
| Q26782196 | The interplay of histone modifications - writers that read |
| Q35955196 | Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer |
Search more.